In drug discovery, translating preclinical findings to clinical success is important for derisking and to avoid costly trial failures and patient risks.
CETSA easily transfers from cell line to animal tissue and human primary cells and can assess target engagement potency and occupancy in tissue from animal studies or patient–isolated material. This facilitates and expedites the evaluation of whether your compounds will have a therapeutic effect in patients.
Get in touch
Contact us to learn more, to book a meeting or request a quote.